2 Money-Burning Biotech Stocks to Avoid
Investing in biotechs is risky enough when you're holding shares of unblemished and outwardly functional companies, so why take a chance on a stock that you know has problems? While sometimes there can be compelling opportunities for contrarians in the biotech space, for many investors, minimizing risk is a bigger priority than maximizing their potential returns.
And that's why it's a good idea to avoid the two biotechs that I'll be discussing today. Neither is in danger of going out of business this year, but both have an unfortunate tendency of burning their investors. Let's explore why.
Image source: Getty Images.
Source Fool.com
